Lotersztajn, Sophie

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 2,897

M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology

Alcohol Consumption and Health EffectsLiver physiology and pathology

Cited by 558

Autophagy in liver diseases: Time for translation?

Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology

Autophagy in Disease and TherapyLiver physiology and pathology

Cited by 378

Hepatic fibrosis: molecular mechanisms and drug targets

Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 325

Mucosal-associated invariant T cells and disease

Toubal, A., Nel, I., Lotersztajn, S., & Lehuen, A. (2019) · Nature Reviews Immunology

T-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Cited by 300

Macrophage autophagy protects against liver fibrosis in mice

Lodder, J., Denaës, T., Chobert, M.-N., Wan, J., El-Benna, J., Pawlotsky, J.-M., Lotersztajn, S., & Teixeira-Clerc, F. (2015) · Autophagy

Liver physiology and pathologyAutophagy in Disease and Therapy

Cited by 266

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver

Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 232

Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis

Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 211

A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis

Hammoutene, A., Biquard, L., Lasselin, J., Kheloufi, M., Tanguy, M., Vion, A.-C., Mérian, J., Colnot, N., Loyer, X., Tedgui, A., et al. (2020) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 188

Pathophysiology of NASH: perspectives for a targeted treatment

Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 163

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis†

Perugorria, M. J., Latasa, M. U., Nicou, A., Cartagena‐Lirola, H., Castillo, J., Goñi, S., Vespasiani‐Gentilucci, U., Zagami, M. G., Lotersztajn, S., Prieto, J., et al. (2008) · Hepatology

Liver physiology and pathologyWound Healing and Treatments

Cited by 151

MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming

Mabire, M., Hegde, P., Hammoutene, A., Wan, J., Caër, C., Sayegh, R. A., Cadoux, M., Allaire, M., Weiss, E., Thibault-Sogorb, T., et al. (2023) · Nature Communications

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 93

Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver

Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., et al. (2019) · Gut

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 91

Autophagy in chronic liver diseases: the two faces of Janus

Gual, P., Gilgenkrantz, H., & Lotersztajn, S. (2017) · American Journal of Physiology-Cell Physiology

Autophagy in Disease and TherapyLiver physiology and pathology

Cited by 91

LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling

Wan, J., Weiss, E., Ben Mkaddem, S., Mabire, M., Choinier, P.-M., Picq, O., Thibault-Sogorb, T., Hegde, P., Pishvaie, D., Bens, M., et al. (2020) · Science Translational Medicine

Autophagy in Disease and TherapyPhagocytosis and Immune Regulation

Cited by 77

Targeting cell-intrinsic metabolism for antifibrotic therapy

Gilgenkrantz, H., Mallat, A., Moreau, R., & Lotersztajn, S. (2021) · Journal of Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 76

Interleukins‐17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation

Guillot, A., Gasmi, I., Brouillet, A., Ait‐Ahmed, Y., Calderaro, J., Ruiz, I., Gao, B., Lotersztajn, S., Pawlotsky, J., & Lafdil, F. (2018) · Hepatology Communications

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 38

The liver X receptor in hepatic stellate cells: a novel antifibrogenic target?

Mallat, A., & Lotersztajn, S. (2011) · Journal of Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 11